AKT1 and depressive symptom measurement: In a subsequent validation experiment, She et al., 2022 demonstrated that EXD significantly upregulates the phosphorylation of Akt1 and the protein and mRNA expression levels of BDNF, PSD95, and SYN in the hippocampus of the MS-RS-induced depression mouse model.